Blog | HemaCare

T cells, STINGVAX, Shrinking Tumors, Oh My!

Jun 1, 2015 1:00:51 PM / by Daisy posted in Cancer Immunology, cancer vaccine, CRS-207, GVAX, immunotherapy, research, STINGVAX, vaccine adjvant

0 Comments

Scientists use PBMC from HemaCare for experiments that show the potential of a new cancer vaccine adjuvant. T cells answer the alarm!

Read More

Dendritic Cells in Precision Medicine

May 4, 2015 1:00:03 PM / by Daisy posted in Cancer Immunology, cancer vaccine, immunotherapy, Independent validation, manufacturing, RNA vaccine

0 Comments

Researchers explore a new, less expensive option for manufacturing dendritic cells as cancer vaccines. HemaCare helped make it possible.

Precision medicine has become quite the catchphrase. In essence, it is an approach towards embracing medical therapy that is precise for the individual. One strategy relies on the patient’s genome. This entails pinpointing DNA mutations and proteins on patient biopsy samples using molecular diagnostics, as the same disease can have diverse causes in different patients. Such knowledge then leads to targeted therapy effective at the molecular level.

Read More

Tracking Trekking Stem Cells

Dec 1, 2014 1:00:29 PM / by Daisy posted in cancer vaccine, Dendritic cells, fluorine-19, MRI, research, stem cells

0 Comments

Stem cells are lost in the fog of other cells once administered into the body. With MRI and fluorine-19 labeling, we could track their trek.

Read More

Information in PBMC Useful for Cancer Vaccine Design

Nov 12, 2014 1:00:58 PM / by Daisy posted in cancer vaccine, drug design, neoepitope, research

0 Comments

We could be headed towards developing cancer vaccines using genomic and proteomic information from PBMC.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts